Cayston

Cayston is an inhaled antibiotic solution used to treat respiratory infections in cystic fibrosis patients. It contains aztreonam, a monobactam antibiotic, and is administered via nebulization.

Cayston is primarily used to manage respiratory infections caused by Pseudomonas aeruginosa in individuals with cystic fibrosis. This medication is designed for inhalation, targeting the lungs directly. Patients often wonder, 'What is Cayston used for?' It is specifically formulated to help control bacterial infections in the airways, improving respiratory function and quality of life for those with cystic fibrosis.

Common effects of Cayston may include coughing, wheezing, or throat irritation during or after inhalation. Some users might experience headache or nasal congestion. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Cayston should be used as directed by a healthcare professional. It is important to follow proper inhalation techniques to ensure effective delivery to the lungs. Patients should be aware of potential allergic reactions and discontinue use if severe symptoms occur. Always store Cayston according to the manufacturer's instructions to maintain its efficacy.

Cayston may interact with other medications, particularly those that affect lung function or immune response. It is advisable to inform your healthcare provider about all medications you are taking. Avoid using Cayston with other inhaled medications without professional guidance to prevent potential interactions.